subscribeSubscribe
price-trendAsk Us
FDA approves new formulation Gilead`s Epclusa for Kids ages 3 and older with HCV

FDA approves new formulation Gilead`s Epclusa for Kids ages 3 and older with HCV
Jonathan.M SEEKING ALPHA
10 Jun 2021
Share Share
FDA OKs Gilead’s paediatric hep C drug

FDA OKs Gilead’s paediatric hep C drug
Anna Smith PHARMATIMES
20 Mar 2020
Share Share
U.S. Food And Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir

U.S. Food And Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir
BUSINESSWIRE
19 Mar 2020
Share Share
Gilead airs first ads for hep C brand Epclusa

Gilead airs first ads for hep C brand Epclusa
Beth S Bulik FIERCE PHARMA
05 Feb 2019
Share Share
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Epclusa®

Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Epclusa®
PRESS RELEASE
08 Jan 2019
Share Share
AbbVie`s latest hep C push highlights Mavyret`s time-to-cure advantage

AbbVie`s latest hep C push highlights Mavyret`s time-to-cure advantage
Beth S Bulik FIERCE PHARMA
13 Dec 2018
Share Share
Hookipa Biotech and Gilead Ink Deal to Develop HIV and Hepatitis B Therapies

Hookipa Biotech and Gilead Ink Deal to Develop HIV and Hepatitis B Therapies
Mark Terry BIOSPACE
05 Jun 2018
Share Share